Loading calculators...
Fetching calculator categories and tools for this section.
Preparing tools and content for you. This usually takes a second.
Fetching calculator categories and tools for this section.
Quick answer
Warfarin is adjusted by changing the total weekly dose by 5–20%, based on how far the INR is from the target. For a 2.0–3.0 target: INR below 1.5 → increase 10–20%; 1.5–1.9 → increase 5–15%; 2.0–3.0 → no change; 3.1–3.4 → decrease 5–10% (hold ½–1 dose at 3.3+); 3.5–3.9 → hold 1 dose, decrease 5–15%; 4.0 or higher → hold until below 3.0, then decrease 5–15%. Example: INR 3.6 on 35 mg/week → skip one dose, then 32.5 mg/week (5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 2.5 mg on Sun). Recheck INR in 1–2 weeks.
Enter today’s INR, your target range and your current dose (same daily dose, a different dose by day, or a weekly total). The calculator applies the UW Medicine maintenance nomogram, CHEST 2012 guidance and BNF high-INR thresholds, then builds a new day-by-day schedule with the tablet strength you have and tells you when to recheck.
For education and double-checking only. Warfarin changes must come from your anticoagulation clinic, pharmacist or doctor. Any bleeding, a fall with head injury, black stools or a severe headache needs urgent care.
Last updated October 2, 2026. Checked against the UW Medicine nomogram, CHEST 2012, AAFP, BC Guidelines and the BNF. · adjust by INR · a 10% weekly change
Try a real example:
INR 3.6 · target 2.0–3.0 · row 3.5–3.9
INR 3.6 → hold 1 dose, then decrease to about 32.5 mg per week (−7.1%).
Consider holding 1 dose; if a maintenance change is needed, decrease the weekly dose by 5–15%.
Current weekly dose
35 mg
avg 5 mg/day
Nomogram change
−5% to −15%
29.75 mg–33.25 mg/week
Hold / booster
Hold
Hold 1 dose
Recheck INR
Within 1–2 weeks after a dose change
Suggested weekly schedule: 32.5 mg
Mon
5 mg
1 × 5 mg
Tue
5 mg
1 × 5 mg
Wed
5 mg
1 × 5 mg
Thu
5 mg
1 × 5 mg
Fri
5 mg
1 × 5 mg
Sat
5 mg
1 × 5 mg
Sun
2.5 mg
½ × 5 mg
How this was calculated
Educational tool based on the UW Medicine maintenance nomogram, CHEST 2012 and BNF/BSH guidance. It does not replace your anticoagulation clinic — never change a warfarin dose without your prescriber’s instructions.
New weekly dose = current weekly dose × (1 ± percent change). The percent comes from the INR row of the nomogram. For INR 3.6 on a 2–3 target, the row says hold one dose and lower the weekly dose 5–15%: 35 mg × 0.95 to 0.85 = 33.25 mg to 29.75 mg. The closest schedule with 5 mg tablets and half tablets is 32.5 mg (−7.1%): 5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 2.5 mg on Sun. The INR is rechecked 1–2 weeks later.
Used for atrial fibrillation, DVT/PE and most mechanical aortic valves. The example column applies each row to someone on 5 mg daily (35 mg/week) with 5 mg tablets.
| INR | Hold / booster | Weekly dose change | Example: 35 mg/week → | Recheck INR |
|---|---|---|---|---|
| < 1.5 | Optional booster 1½–2× daily dose | +10% to +20% | 40 mg (+14.3%) | Within 1–2 weeks after a dose change |
| 1.5–1.7 | Optional booster 1½–2× daily dose | +5% to +15% | 37.5 mg (+7.1%) | Within 1–2 weeks after a dose change |
| 1.8–1.9 | Optional booster 1½–2× daily dose | +5% to +10% | 37.5 mg (+7.1%) | Within 1–2 weeks after a dose change |
| 2.0–3.0 | — | No change | 35 mg | Every 4–8 weeks if stable (CHEST allows up to 12 weeks for consistently stable INRs) |
| 3.1–3.2 | — | −5% to −10% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 3.3–3.4 | Hold ½ to 1 dose | −5% to −10% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 3.5–3.9 | Hold 1 dose | −5% to −15% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 4.0–4.9 | Hold warfarin until the INR is below 3.0 | −5% to −15% | 32.5 mg (−7.1%) | In 1–2 days after holding for over-anticoagulation |
| 5.0–8.0 | Withhold 1 or 2 doses | −10% to −20% | 30 mg (−14.3%) | In 1–2 days |
| > 8.0 | Stop warfarin until the clinic advises | −20% | 27.5 mg (−21.4%) | Within 24 hours (repeat after vitamin K) |
Rows up to 4.9 come from the UW Medicine maintenance nomogram; 5.0 and above follow BNF/BSH guidance. In the 1.8–1.9 and 3.1–3.2 rows, no change may be needed if the last two INRs were in range.
Used for mechanical mitral valves and mechanical aortic valves with extra risk factors. Every low and high threshold is 0.5 higher than the 2–3 chart.
| INR | Hold / booster | Weekly dose change | Example: 35 mg/week → | Recheck INR |
|---|---|---|---|---|
| < 2.0 | Optional booster 1½–2× daily dose | +10% to +20% | 40 mg (+14.3%) | Within 1–2 weeks after a dose change |
| 2.0–2.2 | Optional booster 1½–2× daily dose | +5% to +15% | 37.5 mg (+7.1%) | Within 1–2 weeks after a dose change |
| 2.3–2.4 | Optional booster 1½–2× daily dose | +5% to +10% | 37.5 mg (+7.1%) | Within 1–2 weeks after a dose change |
| 2.5–3.5 | — | No change | 35 mg | Every 4–8 weeks if stable (CHEST allows up to 12 weeks for consistently stable INRs) |
| 3.6–3.7 | — | −5% to −10% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 3.8–3.9 | Hold ½ to 1 dose | −5% to −10% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 4.0–4.4 | Hold 1 dose | −5% to −15% | 32.5 mg (−7.1%) | Within 1–2 weeks after a dose change |
| 4.5–4.9 | Hold warfarin until the INR is below 3.5 | −5% to −15% | 32.5 mg (−7.1%) | In 1–2 days after holding for over-anticoagulation |
| 5.0–8.0 | Withhold 1 or 2 doses | −10% to −20% | 30 mg (−14.3%) | In 1–2 days |
| > 8.0 | Stop warfarin until the clinic advises | −20% | 27.5 mg (−21.4%) | Within 24 hours (repeat after vitamin K) |
These are the situations people search for most, run through the same calculator.
| Situation | Nomogram row | Result |
|---|---|---|
| INR 3.6, target 2–3, 40 mg/week (2.5 mg tablets) | 3.5–3.9 (−5% to −15%) | Hold 1 dose; 36.25 mg/week (−9.4%) — 6.25 mg on Mon; 5 mg on Tue, Wed, Thu, Fri, Sat, Sun |
| INR 3.4, target 2–3, 7 mg daily | 3.3–3.4 (−5% to −10%) | Hold ½ to 1 dose; 45.5 mg/week (−7.1%) — 6.5 mg on every day |
| INR 3.25, target 2–3, 6 mg daily | 3.3–3.4 (−5% to −10%) | Hold ½ to 1 dose; 39 mg/week (−7.1%) — 6 mg on Mon, Tue, Wed, Thu, Fri, Sat; 3 mg on Sun |
| INR 4.4 (up from 2.56), on 6, 6, 5, 6, 6, 6, 6 mg | 4.0–4.9 (−5% to −15%) | Hold warfarin until the INR is below 3.0; 37 mg/week (−9.8%) — 5.5 mg on Mon, Tue, Thu, Sat; 5 mg on Wed, Fri, Sun |
| INR 1.7, target 2–3, 5 mg daily | 1.5–1.7 (+5% to +15%) | 37.5 mg/week (+7.1%) — 7.5 mg on Mon; 5 mg on Tue, Wed, Thu, Fri, Sat, Sun |
| INR 4.8, mechanical mitral valve (target 2.5–3.5), 5 mg daily | 4.5–4.9 (−5% to −15%) | Hold warfarin until the INR is below 3.5; 32.5 mg/week (−7.1%) — 5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 2.5 mg on Sun |
| INR 7.5, no bleeding, 5 mg daily | 5.0–8.0 (−10% to −20%) | Withhold 1 or 2 doses; restart about 30 mg/week; call the clinic today |
| INR 3.0 on 2 mg × 3 days + 1 mg × 4 days | 2.0–3.0 (No change) | Keep 10 mg/week |
| INR 3.2, stable for months, 35 mg/week | 3.1–3.2 (−5% to −10%) | Stable: keep 35 mg and recheck in 1–2 weeks; otherwise 32.5 mg/week (−7.1%) — 5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 2.5 mg on Sun |
| INR 1.3 after missed doses, 5 mg daily | < 1.5 (+10% to +20%) | INR 1.3 with a temporary cause: consider a one-time booster, then usually resume 35 mg per week; without a cause, increase to about 40 mg per week (+14.3%). |
New weekly total (mg) after each percent change. Round to what your tablets allow.
| Weekly (daily avg) | −20% | −15% | −10% | −5% | +5% | +10% | +15% | +20% |
|---|---|---|---|---|---|---|---|---|
| 10 (1.43) | 8 | 8.5 | 9 | 9.5 | 10.5 | 11 | 11.5 | 12 |
| 15 (2.14) | 12 | 12.75 | 13.5 | 14.25 | 15.75 | 16.5 | 17.25 | 18 |
| 17.5 (2.5) | 14 | 14.88 | 15.75 | 16.63 | 18.38 | 19.25 | 20.13 | 21 |
| 20 (2.86) | 16 | 17 | 18 | 19 | 21 | 22 | 23 | 24 |
| 25 (3.57) | 20 | 21.25 | 22.5 | 23.75 | 26.25 | 27.5 | 28.75 | 30 |
| 30 (4.29) | 24 | 25.5 | 27 | 28.5 | 31.5 | 33 | 34.5 | 36 |
| 35 (5) | 28 | 29.75 | 31.5 | 33.25 | 36.75 | 38.5 | 40.25 | 42 |
| 40 (5.71) | 32 | 34 | 36 | 38 | 42 | 44 | 46 | 48 |
| 45 (6.43) | 36 | 38.25 | 40.5 | 42.75 | 47.25 | 49.5 | 51.75 | 54 |
| 50 (7.14) | 40 | 42.5 | 45 | 47.5 | 52.5 | 55 | 57.5 | 60 |
| 60 (8.57) | 48 | 51 | 54 | 57 | 63 | 66 | 69 | 72 |
| 70 (10) | 56 | 59.5 | 63 | 66.5 | 73.5 | 77 | 80.5 | 84 |
Each 2.5 mg step is one half tablet; larger doses are spread across the week.
| Weekly total | Schedule |
|---|---|
| 20 mg | 5 mg on Mon; 2.5 mg on Tue, Wed, Thu, Fri, Sat, Sun |
| 22.5 mg | 5 mg on Mon, Thu; 2.5 mg on Tue, Wed, Fri, Sat, Sun |
| 25 mg | 5 mg on Mon, Wed, Fri; 2.5 mg on Tue, Thu, Sat, Sun |
| 27.5 mg | 5 mg on Mon, Tue, Thu, Sat; 2.5 mg on Wed, Fri, Sun |
| 30 mg | 5 mg on Mon, Tue, Wed, Fri, Sat; 2.5 mg on Thu, Sun |
| 32.5 mg | 5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 2.5 mg on Sun |
| 35 mg | 5 mg on every day |
| 37.5 mg | 7.5 mg on Mon; 5 mg on Tue, Wed, Thu, Fri, Sat, Sun |
| 40 mg | 7.5 mg on Mon, Thu; 5 mg on Tue, Wed, Fri, Sat, Sun |
| 42.5 mg | 7.5 mg on Mon, Wed, Fri; 5 mg on Tue, Thu, Sat, Sun |
| 45 mg | 7.5 mg on Mon, Tue, Thu, Sat; 5 mg on Wed, Fri, Sun |
| 47.5 mg | 7.5 mg on Mon, Tue, Wed, Fri, Sat; 5 mg on Thu, Sun |
| 50 mg | 7.5 mg on Mon, Tue, Wed, Thu, Fri, Sat; 5 mg on Sun |
| Situation | Action | Source |
|---|---|---|
| INR above range but < 5, no bleeding | Lower the weekly dose or omit a dose (see the nomogram rows above); more frequent INR checks. | UW Medicine, BC Guidelines |
| INR 5.0–8.0, no bleeding | Withhold 1 or 2 doses and reduce the maintenance dose. | BNF / BSH |
| INR 4.5–10, no bleeding | Vitamin K is not routinely recommended — holding warfarin is usually enough. | CHEST 2012 (Grade 2B) |
| INR > 8 (BNF) or > 10 (CHEST), no bleeding | Stop warfarin; a clinician gives oral vitamin K and repeats the INR in 24 h; restart when INR < 5. | BNF / CHEST 2012 |
| INR 5–8 or > 8 with minor bleeding | Stop warfarin; IV vitamin K given by a clinician; restart when INR < 5. | BNF / BSH |
| Major bleeding at any INR | Emergency care: stop warfarin, IV vitamin K plus prothrombin complex concentrate (4-factor PCC). | CHEST 2012, BNF |
| Situation | Next INR |
|---|---|
| A dose was held today for significant over-anticoagulation | In 1–2 days |
| Dose changed today | Within 1–2 weeks |
| Dose changed less than 2 weeks ago (now in range) | Within 2–4 weeks |
| Stable, reliable patient, in range | Every 4–8 weeks (CHEST: up to 12 weeks if consistently stable) |
| Unstable or unreliable patient | Every 1–2 weeks |
| After hospital discharge | 1–3 days if unstable, 3–7 days if stable |
From the UW Medicine monitoring schedule; CHEST 2012 allows up to 12 weeks between tests for consistently stable patients.
| Indication | INR target | Source |
|---|---|---|
| Atrial fibrillation (non-valvular) | 2.0–3.0 (aim 2.5) | CHEST |
| DVT or pulmonary embolism (VTE) | 2.0–3.0 (aim 2.5) | CHEST |
| Mechanical aortic valve (bileaflet or current tilting disc), no risk factors | Aim 2.5 (2.0–3.0) | ACC/AHA 2020 |
| Mechanical aortic valve with risk factors (AF, prior clot, LV dysfunction, hypercoagulable) or older valve | Aim 3.0 (2.5–3.5) | ACC/AHA 2020 |
| Mechanical mitral valve | Aim 3.0 (2.5–3.5) | ACC/AHA 2020 |
| On-X mechanical aortic valve, no risk factors, after 3 months | 1.5–2.0 with aspirin | ACC/AHA 2020 (Class 2b) |
DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) are not used with mechanical heart valves — warfarin remains the anticoagulant for them.
| US strength | Color |
|---|---|
| 1 mg | Pink |
| 2 mg | Lavender |
| 2.5 mg | Green |
| 3 mg | Tan |
| 4 mg | Blue |
| 5 mg | Peach |
| 6 mg | Teal |
| 7.5 mg | Yellow |
| 10 mg | White (dye-free) |
| UK strength | Color |
|---|---|
| 0.5 mg | White |
| 1 mg | Brown |
| 3 mg | Blue |
| 5 mg | Pink |
US colors from the Coumadin label; UK colors from the emc leaflet. Always check the milligrams, not just the color.
| Drug or factor | Effect | Note |
|---|---|---|
| Amiodarone | Raises INR | Major; effect builds over weeks |
| Metronidazole, sulfamethoxazole (Bactrim), fluconazole and other azoles | Raises INR | Major; check INR within days of starting |
| Ciprofloxacin, levofloxacin, clarithromycin, erythromycin | Raises INR | Major |
| Acetaminophen (regular use) | Raises INR | Moderate; matters with daily use |
| Alcohol | Acute binge raises INR; chronic heavy use lowers it | Keep intake small and steady |
| Thyroid hormone (starting or increasing) | Raises INR | Major |
| Rifampin/rifamycins, carbamazepine, phenobarbital | Lowers INR | Enzyme inducers; doses may need large increases |
| Vitamin K (supplements, large changes in leafy greens) | Lowers INR | Keep vitamin K intake consistent, not zero |
| Aspirin, NSAIDs (ibuprofen, naproxen), clopidogrel | No INR change but more bleeding | Usually avoid unless prescribed together |
Selected from the UW Medicine interaction table and the FDA label. Get an INR within a few days of starting or stopping any of these.
Warfarin’s effective half-life is 20–60 hours (mean about 40), so any change takes roughly a week to settle. Judging a dose change after two or three days overreacts to a moving number.
The dose–INR curve is steep and non-linear, so modest dose changes can move the INR a lot. Average maintenance doses are around 4–6 mg a day but vary widely with age, genetics (CYP2C9, VKORC1), diet, liver function and other drugs.
Working in weekly totals lets small steps (2.5 mg out of 35 mg = 7%) fit what tablets can deliver. Holds and boosters fix today’s INR; the percent change fixes next week’s.
Every chart and example on this page is generated by the same code that runs the calculator. The dosing rows match the UW Medicine nomogram exactly; high-INR thresholds, vitamin K and recheck advice are cross-checked with CHEST 2012, the BNF and BC Guidelines.
Medical disclaimer: this page is educational and does not provide medical advice. It does not cover starting doses, bridging, procedures, pregnancy, children or genotype-guided dosing. Follow the instructions of the clinician who manages your warfarin.
On warfarin for atrial fibrillation? See your stroke risk with the CHA₂DS₂-VASc calculator. Running an anticoagulation clinic or pharmacy? We build custom dosing tools.
Get Custom Calculator for Your BusinessSuggested hashtags: #Warfarin #INR #Anticoagulation #Pharmacy